NKGen Biotech, Inc. Warrants
NKGNW
NKGNW was delisted on the 4th of March, 2025.
32 hedge funds and large institutions have $1.52M invested in NKGen Biotech, Inc. Warrants in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 4 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
9% less funds holding
Funds holding: 35 → 32 (-3)
11% less capital invested
Capital invested by funds: $1.72M → $1.52M (-$197K)
75% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MF
Magnetar Financial
Evanston,
Illinois
|
+$31.6K |
| 2 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$21.3K |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
+$6.88K |
| 4 |
SCM
Saba Capital Management
New York
|
+$5.36K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
CH
26
CVI Holdings
Wilmington,
Delaware
| $3K | – | – | – |
|
|
GCIA
27
Gabelli & Co Investment Advisers
Rye,
New York
| $3K | – | – | – |
|
28
JP Morgan Chase
New York
| $3K | – | – | – |
|
|
CCM
29
CAAS Capital Management
New York
| $2K | – | – | – |
|
|
SC
30
Sculptor Capital
New York
| $2K | – | – | – |
|
31
Walleye Capital
New York
| $2K | – | – | – |
|
|
PI
32
PEAK6 Investments
Chicago,
Illinois
| $1K | -$1.9K | -11,039 | -50% |
|
33
Parallax Volatility Advisers
San Francisco,
California
| – | -$7K | -26,329 | Closed |
|
|
VCIM
34
Velan Capital Investment Management
Alpharetta,
Georgia
| – | -$5K | -20,000 | Closed |
|
|
COPPSERS
35
Commonwealth of Pennsylvania Public School Employees Retirement System
Harrisburg,
Pennsylvania
| – | -$3K | -10,000 | Closed |
|
|
FLC
36
Fifth Lane Capital
Austin,
Texas
| – | -$2K | -7,920 | Closed |
|
NKGNW Hedge Fund Activity: Q3 2022 in Review
32 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in NKGen Biotech, Inc. Warrants (NKGNW) for Q3 2022, worth a combined $1.52M — down 11% from $1.72M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NKGNW and 1 opened new positions — a net loss of 3 holders — while 3 trimmed existing stakes and 3 added.
The largest buyer was Magnetar Financial, adding an estimated $31.6K. The largest seller was Fir Tree Capital Management, cutting an estimated $8.75K.
- 32 institutional investors held NKGen Biotech, Inc. Warrants (NKGNW) as of Q3 2022, down from 35 in Q2 2022.
- Funds reported $1.52M of NKGen Biotech, Inc. Warrants stock for Q3 2022, down 11% quarter-over-quarter.
- 1 fund opened new NKGen Biotech, Inc. Warrants positions in Q3 2022 and 4 closed out, a net change of -3 holders.
- The largest NKGen Biotech, Inc. Warrants buyer in Q3 2022 was Magnetar Financial, an estimated $31.6K added.
- The largest NKGen Biotech, Inc. Warrants seller in Q3 2022 was Fir Tree Capital Management, an estimated $8.75K sold.
Based on aggregated 13F filings for Q3 2022.